NextBio logo — company profile

NextBio

Founded 2004 United States Santa Clara, United States 32 employees Series C Total: $16.10M Biotechnology, Enterprise Software +2

General Information

Company Name NextBio
Founded Year 2004
Location United States Santa Clara, United States +1
Employees 32
Industries Biotechnology, Enterprise Software, Health Care +1
Funding Stage Series C
Social

Get notified when NextBio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About NextBio

NextBio is a biotechnology startup founded in 2004, headquartered in the United States. The company offers an innovative platform for life science researchers, enabling them to unlock knowledge within public and proprietary data. Their seamless SaaS solution has garnered support from investors, including Signatures Capital and Newbury Ventures, who made an $8.00M Series C investment on 18 September 2009. NextBio's platform combines powerful tools with unique correlated content, transforming information into knowledge and laying the foundation for new scientific discoveries. It aims to assist organizations in increasing productivity and improving collaboration across therapeutic groups and geographic boundaries in the fields of biotechnology, enterprise software, and healthcare.

Taxonomy: Life science research, Research collaboration, Knowledge discovery, Scientific discovery, Data integration, Biomedical research, Information transformation, Collaborative tools, Productivity enhancement, Public and proprietary data, Therapeutic groups, Rapid deployment, Return on investment

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 2
Investor Investor
18 Sep 2009
Series B •••••• 2
Investor Investor
06 Jun 2007
Series A •••••• 1
Investor
01 Jan 2005

NextBio Alternatives & Competitors

NextBio vs
ONTOFORCE
ONTOFORCE Belgium

Through our data and technology solutions, we transform data into actionable insights, and streamlin...

Series A
34 employees
Analytics, Biotechnology
NextBio vs

Researching is difficult, AI can help find interdisciplinary knowledge for breakthrough discoveries.

NextBio vs

Ensol Biosciences develops innovative new drugs to cure the incurables with a bio big data platform...

Series C
7 employees
Biotechnology
Also compare with: NextBio vs Drug Hunter Drug Hunter

FAQ About NextBio

NextBio is the provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data. NextBio's platform seamlessly combines powerful tools with unique correlated content to transform information into knowledge, pr...
NextBio was founded in 2004.
NextBio is headquartered in Santa Clara, United States.
NextBio operates in the following industries: Biotechnology, Enterprise Software, Health Care, Life Sciences.
NextBio has approximately 32 employees.
NextBio has completed 3 funding rounds, raising a total of $16.10M. The latest funding stage is Series C.
Top alternatives and competitors to NextBio include ONTOFORCE, Goddard – Discovery, Ensol Biosciences Inc., Expontum, Drug Hunter. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
NextBio and ONTOFORCE are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors NextBio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy